Schrodinger, Inc. Net Income 2019-2024 | SDGR
Schrodinger, Inc. net income from 2019 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Schrodinger, Inc. Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $41 |
| 2022 | $-149 |
| 2021 | $-100 |
| 2020 | $-24 |
| 2019 | $-25 |
| 2018 | $-28 |
| Schrodinger, Inc. Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-38 |
| 2024-06-30 | $-54 |
| 2024-03-31 | $-55 |
| 2023-12-31 | $-31 |
| 2023-09-30 | $-62 |
| 2023-06-30 | $4 |
| 2023-03-31 | $129 |
| 2022-12-31 | $-27 |
| 2022-09-30 | $-40 |
| 2022-06-30 | $-48 |
| 2022-03-31 | $-34 |
| 2021-12-31 | $-31 |
| 2021-09-30 | $-35 |
| 2021-06-30 | $-35 |
| 2021-03-31 | $-0 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $4 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-14 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-12 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||